Literature DB >> 8426174

One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome.

K M Carroll1, M E Power, K Bryant, B J Rounsaville.   

Abstract

While the prognostic significance of comorbid psychopathology and dependence severity has been demonstrated with opiate addicts and alcoholics, no previous reports have examined these issues in cocaine abusers. We reinterviewed 94 cocaine abusers 1 year after they sought treatment to assess predictors of treatment retention and outcome. Results suggested that: a) Many cocaine abusers did comparatively well; fully a third reported complete abstinence during the 12 months preceding the follow-up interview. b) Three variables emerged as consistent predictors across several outcome domains: severity of drug use, poorer psychiatric functioning, and presence of concurrent alcoholism. c) The data supported a unidimensional model of outcome for cocaine abuse that emphasized reduction in level of substance use. However, abstinence was not strongly associated with improved functioning in all outcome areas. d) Variables associated with longer retention in treatment also tended to predict poorer outcome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426174     DOI: 10.1097/00005053-199302000-00001

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  44 in total

1.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

2.  A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers.

Authors:  Christy K Scott
Journal:  Drug Alcohol Depend       Date:  2004-04-09       Impact factor: 4.492

Review 3.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

4.  Predictors of longitudinal substance use and mental health outcomes for patients in two integrated service delivery systems.

Authors:  Christine E Grella; Judith A Stein; Constance Weisner; Felicia Chi; Rudolf Moos
Journal:  Drug Alcohol Depend       Date:  2010-03-24       Impact factor: 4.492

5.  Psychosocial treatments for cocaine dependence: the role of depressive symptoms.

Authors:  Niklaus Stulz; Michael E Thase; Robert Gallop; Paul Crits-Christoph
Journal:  Drug Alcohol Depend       Date:  2011-03-01       Impact factor: 4.492

Review 6.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

7.  Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.

Authors:  Christine E Grella; Judith A Stein
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

8.  Psychiatric Symptom Improvement in Women Following Group Substance Abuse Treatment: Results from the Women's Recovery Group Study.

Authors:  R Kathryn McHugh; Shelly F Greenfield
Journal:  J Cogn Psychother       Date:  2010-04-01

9.  Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.

Authors:  Paul Crits-Christoph; Steven Wadden; Averi Gaines; Agnes Rieger; Robert Gallop; James R McKay; Mary Beth Connolly Gibbons
Journal:  J Subst Abuse Treat       Date:  2018-06-21

10.  Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.

Authors:  Frances R Levin; Adam Bisaga; Wilfrid Raby; Efrat Aharonovich; Eric Rubin; John Mariani; Daniel J Brooks; Fatima Garawi; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2007-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.